Medicus Pharma Advances SkinJect® into Registrational Development for Gorlin Syndrome

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ACN
3. NVDA
4. MU
5. GOOGL
6. USO
7. APGE
8. ABBV
9. DFTX
10. MSFT

Go back to Medicus Pharma Advances SkinJect® into Registrational Development for Gorlin Syndrome
(NASDAQ: MDCX) Delayed: 0.45 --0 (-0%)
Previous Close $0.45    52 Week High $ 
Open $0.45    52 Week Low $ 
Day High $0.45    P/E N/A 
Day Low $0.45    EPS $ 
Volume 26,429       

(NASDAQ: MDCX) Delayed: 0.45 --0 (-0%)
Previous Close $0.45    52 Week High $ 
Open $0.45    52 Week Low $ 
Day High $0.45    P/E N/A 
Day Low $0.45    EPS $ 
Volume 26,429